- Linking Oxytocin and Vasopressin: A Novel Pathway for Autism Therapy Neuroscience News
- Study demonstrates clinically relevant deficiency of the ‘bonding hormone’ oxytocin Medical Xpress
- “Bonding hormone” oxytocin is clinically deficient: Study ETHealthWorld
- Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial The Lancet
- View Full Coverage on Google News
Read More: Linking Oxytocin and Vasopressin: A Novel Pathway for Autism Therapy –